Biotechnology
A Look Into What’s Causing MYM Nutraceuticals’ Stock Growth
MYM Nutraceuticals Inc. (OTCQB:MYMMF) (TSXV:MYM), a company that focuses on producing and selling medicinal marijuana, has seen its stock increase to $3.33 at the time of writing, which is up $0.58 (or 21%) from yesterday’s ... [Read]
Biotechnology
Eleven Biotherapeutics Reaping the Benefits of U.S. Market Shareholders Awaiting Vote on U.S. Tax Bill
On Monday, United States stocks closed at an all-time high. The reason? Investors were waiting to see the results of a bill which would, if passed, slash corporate taxes. Further, because of shareholders awaiting a ... [Read]
Biotechnology
Here’s Why Aratana Therapeutics Stock Dropped Today
As of 1:16 p.m. EST on Tuesday, December 19, shares of Aratana Therapeutics, Inc. (NASDAQ:PETX) are down 1.79%. The company has a market capitalization of $236.07 million. This is not overly surprising considering the Leawood, ... [Read]
Biotechnology
Spectrum Pharmaceuticals Terminates CEO, Appoints New CEO
Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) has terminated its CEO Rajesh Shrotriya and has appointed Joseph Turgeon as the company’s new CEO. Turgeon, who was previously the COO, will still maintain his position as President of the ... [Read]
Biotechnology
Denali Therapeutics Raises the Year’s Largest Biotech IPO
Denali Therapeutics (NASDAQ:DNLI) managed to raise $250 million at a post-money valuation of $1.58 billion. This has put Denali Therapeutics on the list for one of the largest biotechnology IPOs of 2017. If Denali is ... [Read]
Biotechnology
Myriad Genetics Seeing Positive Results from EndoPredict Test Data
Myriad Genetics, Inc. (NASDAQ:MYGN) has made several developments in its EndoPredict studies. The company now has data that shows that the EndoPredict tests are able to predict residual cancer burden in certain cancer patients. The ... [Read]
Biotechnology
Iovance Biotherapeutics Webcasting its Analyst Day on December 13
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) will be webcasting its Analyst Day on Wednesday, December 13 from 9:00 am to 12:00 pm EST. The event, being held in New York City, will highlight Iovance’s lead clinical programs. ... [Read]
Biotechnology
Stock Update for Spectrum Pharmaceuticals
Based on the most recent trading session, shares for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) closed at $18.63, with a change of -3.12%. 677,566 shares traded hands. Spectrum’s stock currently has an average trading capacity of 1.87 ... [Read]
Biotechnology
Spectrum Pharmaceuticals, Inc. Doubles in Three Months – Here’s Why
Shares for Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) have more than doubled in the past three months. With a 110% increase, they are well beyond the comparable 5.3% rise of its corresponding industry. So where has this ... [Read]
Biotechnology
A Closer Look at Iovance Biotherapeutics Inc.’s Recent Trading Lows
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) recently had a low trading volume day. The volume for the company on November 13th was recorded to 0.39 million contracts. Over the past three months, the average daily trading volume ... [Read]